Focus: Novanta is a public medical device manufacturer specializing in surgical cameras and infusion pumps, serving gastroenterology, neurology, ophthalmology, and respiratory markets. With $882M in FY2025 revenue and 1,001–5,000 employees, it operates as a scaled, profitable device business.
Profile data last refreshed 2h ago · AI intelligence enriched 1w ago
Hot — 365 jobs added in 30d
Net +320 (365 new, 45 removed). Aggressive expansion phase.
Novanta is a stable, profitable device manufacturer best suited for operations, manufacturing, and engineering professionals; avoid if seeking clinical development, pipeline innovation, or rapid career trajectory in drug discovery.
Help build intelligence for Novanta
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Novanta's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Showing 6 of 8 news items
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent manufacturing consolidation and offshoring signal cost discipline but elevated restructuring risk for US-based operations and manufacturing roles.